Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
companion diagnostics
MedTech
Roche nets FDA breakthrough label for AI lung cancer CDx test
Roche’s companion test aims to identify non-small cell lung cancer patients who may benefit from Datroway, from AstraZeneca and Daiichi Sankyo.
Conor Hale
Apr 29, 2025 2:07pm
Qiagen, AstraZeneca expand DNA test collaboration beyond cancer
Aug 29, 2024 11:30am
Agilent, Incyte ink hematology, oncology companion testing deal
Jan 30, 2024 12:28pm
Agilent shuts down its Resolution cancer diagnostic business
Aug 22, 2023 10:20am
Tempus clocks FDA approval for 648-gene cancer test
May 8, 2023 8:05am
FDA looks to bypass cancer drugs' companion diagnostics: Pazdur
Nov 18, 2022 9:17am
